Literature DB >> 15613294

Basic statistical considerations in virological experiments.

Barbra A Richardson1, Julie Overbaugh.   

Abstract

Mesh：

Year:  2005        PMID： 15613294      PMCID： PMC538531          DOI： 10.1128/JVI.79.2.669-676.2005

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  6 in total

Review 1.  Viral load as a primary outcome in human immunodeficiency virus trials: a review of statistical analysis methods.

Authors:  V Journot; G Chêne; P Joly; M Savès; H Jacqmin-Gadda; J M Molina; R Salamon
Journal:  Control Clin Trials       Date:  2001-12

Review 2.  Review of the use of statistics in infection and immunity.

Authors:  Cara H Olsen
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

3.  Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge.

Authors:  N A Doria-Rose; C Ohlen; P Polacino; C C Pierce; M T Hensel; L Kuller; T Mulvania; D Anderson; P D Greenberg; S-L Hu; N L Haigwood
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines.

Authors:  Wing-Pui Kong; Yue Huang; Zhi-Yong Yang; Bimal K Chakrabarti; Zoe Moodie; Gary J Nabel
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

5.  Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.

Authors:  Thorsten U Vogel; Matthew R Reynolds; Deborah H Fuller; Kathy Vielhuber; Tim Shipley; James T Fuller; Kevin J Kunstman; Gerd Sutter; Marta L Marthas; Volker Erfle; Steven M Wolinsky; Chenxi Wang; David B Allison; Erling W Rud; Nancy Wilson; David Montefiori; John D Altman; David I Watkins
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 6.  Do multiple outcome measures require p-value adjustment?

Authors:  Ronald J Feise
Journal:  BMC Med Res Methodol       Date:  2002-06-17       Impact factor: 4.615
  6 in total
  27 in total

1.  Construction and characterization of a herpes simplex virus type I recombinant expressing green fluorescent protein: acute phase replication and reactivation in mice.

Authors:  John W Balliet; Anna S Kushnir; Priscilla A Schaffer
Journal:  Virology       Date:  2007-01-17       Impact factor: 3.616

2.  Multisite comparison of anti-human immunodeficiency virus microbicide activity in explant assays using a novel endpoint analysis.

Authors:  Nicola Richardson-Harman; Carol Lackman-Smith; Patricia S Fletcher; Peter A Anton; James W Bremer; Charlene S Dezzutti; Julie Elliott; Jean-Charles Grivel; Patricia Guenthner; Phalguni Gupta; Maureen Jones; Nell S Lurain; Leonid B Margolis; Swarna Mohan; Deena Ratner; Patricia Reichelderfer; Paula Roberts; Robin J Shattock; James E Cummins
Journal:  J Clin Microbiol       Date:  2009-09-02       Impact factor: 5.948

3.  Gammaherpesvirus persistence alters key CD8 T-cell memory characteristics and enhances antiviral protection.

Authors:  Joshua J Obar; Shinichiro Fuse; Erica K Leung; Sarah C Bellfy; Edward J Usherwood
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  The reovirus sigma1s protein is a determinant of hematogenous but not neural virus dissemination in mice.

Authors:  Karl W Boehme; Johnna M Frierson; Jennifer L Konopka; Takeshi Kobayashi; Terence S Dermody
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

5.  Bioinformatics Analysis of Gut Microbiota and CNS Transcriptome in Virus-Induced Acute Myelitis and Chronic Inflammatory Demyelination; Potential Association of Distinct Bacteria With CNS IgA Upregulation.

Authors:  Seiichi Omura; Fumitaka Sato; Ah-Mee Park; Mitsugu Fujita; Sundar Khadka; Yumina Nakamura; Aoshi Katsuki; Kazuto Nishio; Felicity N E Gavins; Ikuo Tsunoda
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

6.  Utilization of sialylated glycans as coreceptors enhances the neurovirulence of serotype 3 reovirus.

Authors:  Johnna M Frierson; Andrea J Pruijssers; Jennifer L Konopka; Dirk M Reiter; Ty W Abel; Thilo Stehle; Terence S Dermody
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

7.  Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus.

Authors:  Patricia V Aguilar; Slobodan Paessler; Anne-Sophie Carrara; Samuel Baron; Joyce Poast; Eryu Wang; Abelardo C Moncayo; Michael Anishchenko; Douglas Watts; Robert B Tesh; Scott C Weaver
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Mutations in envelope gp120 can impact proteolytic processing of the gp160 precursor and thereby affect neutralization sensitivity of human immunodeficiency virus type 1 pseudoviruses.

Authors:  Wendy M Blay; Theresa Kasprzyk; Lynda Misher; Barbra A Richardson; Nancy L Haigwood
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

9.  Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication.

Authors:  Fu-Zhang Wang; Frank Weber; Carlo Croce; Chang-Gong Liu; Xudong Liao; Philip E Pellett
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

10.  Mosquitoes put the brake on arbovirus evolution: experimental evolution reveals slower mutation accumulation in mosquito than vertebrate cells.

Authors:  Nikos Vasilakis; Eleanor R Deardorff; Joan L Kenney; Shannan L Rossi; Kathryn A Hanley; Scott C Weaver
Journal:  PLoS Pathog       Date:  2009-06-05       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.